Simcere Therapeutics - R&D Pipeline
SIM0395 (PI3K/mTOR) Phase111 Glioblastoma (GBM Agile study)
Simcere and Kazia waiting for Chinese regulator's approval to enrol first patient in the study.
Regards.
- Forums
- ASX - By Stock
- KZA
- Simcere Therapeutics
Simcere Therapeutics
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)